Drug intelligence / Profile preview

Huofeitong tablet

Development stage: Unknown
Lead developer: Heyuan Jinyuan Green Life
Administration: Oral

Overview

Huofeitong tablet is a traditional Chinese herbal medicine (TCM) developed by Heyuan Jinyuan Green Life Co., Ltd. for the treatment of stable chronic obstructive pulmonary disease (COPD). It is specifically formulated to address the "lung-kidney deficiency" pattern, a diagnostic category in traditional Chinese medicine. The drug has been evaluated in Phase 2 clinical trials in China (e.g., CTR20131030) to assess its safety and efficacy in improving lung function and respiratory symptoms in patients with stable COPD. As a botanical formulation, it likely contains multiple active herbal ingredients intended to work synergistically to alleviate airway inflammation and improve overall respiratory health.

Brand names: Huofeitong tablet

Beyond the preview

Go deeper on Huofeitong tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huofeitong tablet.

Explore the full profile